Niagen Bioscience starts planning healthy aging clinical trial with Mass General Brigham

Niagen Bioscience said it signed a start-up agreement with Mass General Brigham investigators to begin detailed planning for a proposed multi-year, randomized placebo-controlled prevention trial. The study would evaluate Niagen supplementation in adults aged 50 and older, with final design still subject to planning and agreements.